Nilutamide Tablet — FDA Drug Shortage

To Be Discontinued — Advanz Pharma (US) Corp.

The FDA lists a drug shortage record for Nilutamide Tablet (tablet) from Advanz Pharma (US) Corp. with status To Be Discontinued. The shortage was first posted on 12/01/2025.

Shortage Details

Status
To Be Discontinued
Company
Advanz Pharma (US) Corp.
Package NDC
59212-111-14
Dosage Form
Tablet
Presentation
Nilandron, Tablet, 150 mg (NDC 59212-111-14)
Initial Posting
12/01/2025
Revised Date